Relapse after methylprednisolone oral minipulse therapy in childhood vitiligo: A 12-month follow-up study

• Ngā kaituhi matua: Imran Majid (Author), Saher Imran (Author)
• Hōputu: Pukapuka
• I whakaputaina: Wolters Kluwer Medknow Publications, 2013-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: Oral minipulse (OMP) therapy with methylprednisolone is presently one of the most common oral treatments used for progressive vitiligo in children. The treatment is usually given for a period of 6 months during which majority of patients are reported to go into remission. However, there...